Granulin: Biomarker or interesting window into host/tumor biology?

Gynecologic Oncology

Volumn 120, Issue 1, 2011, Pages 1-2

  Swisher, Elizabeth M ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; GRANULIN; MICRORNA; PROGRANULIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADVANCED CANCER; CANCER RECURRENCE; CANCER REGRESSION; CANCER RELAPSE; EDITORIAL; GLIOMA; HUMAN; LEIOMYOSARCOMA; MULTIPLE MYELOMA; OVARY CARCINOMA; OVERALL SURVIVAL; PERITONEUM CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEOMICS; RECURRENCE RISK; UTERINE TUBE CARCINOMA;

DISEASE PROGRESSION; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; OVARIAN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 78649917953     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.11.001     Document Type: Editorial

References (14)

1. Hartwell L, Mankoff D, Paulovich A, Ramsey S, and Swisher E Cancer biomarkers: a systems approach Nat Biotechnol 24 2006 905 908
2. Bast RC Jr., Feeney M, Lazarus H, Nadler LM, Colvin RB, and Knapp RC Reactivity of a monoclonal antibody with human ovarian carcinoma J Clin Invest 68 1981 1331 1337
3. Markman M, Liu PY, Rothenberg ML, Monk BJ, Brady M, and Alberts DS Pretreatment CA-125 and risk of relapse in advanced ovarian cancer J Clin Oncol 24 2006 1454 1458 (Pubitemid 46622013)
4. Riedinger JM, Wafflart J, Ricolleau G, Eche N, Larbre H, Basuyau JP, Dalifard I, Hacene K, and Pichon MF CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric study Ann Oncol 17 2006 1234 1238
5. van Altena AM, Kolwijck E, Spanjer MJ, Hendriks JC, Massuger LF, and de Hullu JA CA125 nadir concentration is an independent predictor of tumor recurrence in patients with ovarian cancer: a population-based study Gynecol Oncol 119 2010 265 269
6. Rustin GJ, van der Burg ME, Griffin CL, Guthrie D, Lamont A, Jayson GC, Kristensen G, Mediola C, Coens C, Qian W, Parmar MK, and Swart AM Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial Lancet 376 2010 1155 1163
7. Havrilesky LJ, Whitehead CM, Rubatt JM, Cheek RL, Groelke J, He Q, Malinowski DP, Fischer TJ, and Berchuck A Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence Gynecol Oncol 110 2008 374 382
8. Tsukishiro S, Suzumori N, Nishikawa H, Arakawa A, and Suzumori K Use of serum secretory leukocyte protease inhibitor levels in patients to improve specificity of ovarian cancer diagnosis Gynecol Oncol 96 2005 516 519
9. Bateman A, and Bennett HP The granulin gene family: from cancer to dementia Bioessays 31 2009 1245 1254
10. Ho JC, Ip YC, Cheung ST, Lee YT, Chan KF, Wong SY, and Fan ST Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma Hepatology 47 2008 1524 1532
11. Matsumura N, Mandai M, Miyanishi M, Fukuhara K, Baba T, Higuchi T, Kariya M, Takakura K, and Fujii S Oncogenic property of acrogranin in human uterine leiomyosarcoma: direct evidence of genetic contribution in in vivo tumorigenesis Clin Cancer Res 12 2006 1402 1411
12. Tangkeangsirisin W, Hayashi J, and Serrero G PC cell-derived growth factor mediates tamoxifen resistance and promotes tumor growth of human breast cancer cells Cancer Res 64 2004 1737 1743
13. Pan CX, Kinch MS, Kiener PA, Langermann S, Serrero G, Sun L, Corvera J, Sweeney CJ, Li L, Zhang S, Baldridge LA, Jones TD, Koch MO, Ulbright TM, Eble JN, and Cheng L PC cell-derived growth factor expression in prostatic intraepithelial neoplasia and prostatic adenocarcinoma Clin Cancer Res 10 2004 1333 1337 (Pubitemid 38365225)
14. He Z, and Bateman A Progranulin gene expression regulates epithelial cell growth and promotes tumor growth in vivo Cancer Res 59 1999 3222 3229